UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis-Reference-Cited by-同舟云学术

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Published:2022-08 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Abbas Nadir,Culver Emma L.,Thorburn Douglas,Halliday Neil,Crothers Hannah,Dyson Jessica K.,Phaw April,Aspinall Richard,Khakoo Salim I.,Kallis Yiannis,Smith Belinda,Patanwala Imran,McCune Anne,Chimakurthi Chenchu R.,Hegade Vinod,Orrell Michael,Jones Rebecca,Mells George,Thain Colette,Thain Robert-Mitchell,Jones David,Hirschfield Gideon,Trivedi Palak J.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Primary biliary cholangitis;Lleo;Lancet,2020

2. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis;Harms;J Hepatol,2019

3. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study;Lammers;Gastroenterology,2014

4. Pre-treatment prediction of response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis: the UDCA Response Score;Carbone;Lancet Gastroenterol Hepatol,2018

5. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group;Poupon;N Engl J Med,1991

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06

2. Editorial: Unravelling real‐world impact of second‐line therapies in primary biliary cholangitis— Time to change our targets?;Alimentary Pharmacology & Therapeutics;2024-05-21

3. Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice;Alimentary Pharmacology & Therapeutics;2024-05

4. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis;Clinical Gastroenterology and Hepatology;2024-05

5. Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis;Expert Opinion on Investigational Drugs;2024-04-24